Is Biopharma Future-Proof? ESG and Long-Term Planning
CECP’s CEO Investor Forum and the Biopharma Sustainability Roundtable invite you to join us on March 18th at 11:00am – 12:00pm EST / 4:00pm – 5:00pm CET for a lively discussion with representatives from Merck and Calvert on how biopharma companies are moving forward to integrate a sector-specific sustainability perspective into their long-term planning and investor communications.
Attendees will hear how companies are using CECP’s Long-Term Plan framework together with the Biopharma Investor ESG Communications Guidance to increase the value and impact of their communications with investors. Investor representatives who contributed to development of the BSRT Guidance will also share their perspectives on the sector’s effort to forge a common approach to ESG investor communications.
Participants will gain early access to a new executive whitepaper, “Integrating Sustainability and Long-term Planning for the Biopharma Sector,” which will be publicly released on March 22nd by the Biopharma Sustainability Roundtable (BSRT) and CECP’s CEO Investor Forum.
While the discussion will focus on biopharma, it also offers other sectors an effective model for communicating their own high-priority ESG topics in a decision-useful way.